Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Receivables - Other (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Receivables - Other for 13 consecutive years, with $322000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 43.61% to $322000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $322000.0 through Dec 2025, down 43.61% year-over-year, with the annual reading at $322000.0 for FY2025, 43.61% down from the prior year.
  • Receivables - Other for Q4 2025 was $322000.0 at Plus Therapeutics, down from $1.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $1.0 million in Q2 2025, with the low at $73000.0 in Q3 2022.
  • Average Receivables - Other over 4 years is $466000.0, with a median of $446500.0 recorded in 2024.
  • The sharpest move saw Receivables - Other grew 24.66% in 2023, then tumbled 43.61% in 2025.
  • Over 4 years, Receivables - Other stood at $73000.0 in 2022, then grew by 24.66% to $91000.0 in 2023, then soared by 527.47% to $571000.0 in 2024, then crashed by 43.61% to $322000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $322000.0, $1.0 million, and $571000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.